Presentation Information
[1P-230]Drug design for cyclin-dependent kinase 9 (CDK9) inhibitors in silico
○Kaori Asamitsu1, Takatsugu Hirokawa2, Takashi Okamoto1 (1. Nagoya City University, 2. University of Tsukuba)
Comment
To browse or post comments, you must log in.Log in
